With the tightening of borders, Pakistan-based narcotic cartels are increasingly depending on locals in India to manufacture and supply drugs. Officials highlight the shift towards local drug production due to the challenges in smuggling narcotics across the borders. Even the Punjab border, previously a common route for drug smuggling, has become more difficult to breach, prompting cartels to explore alternative methods.
Intelligence reports suggest that the Dawood Syndicate has mobilized its operatives in India to engage in large-scale local drug manufacturing. Leveraging the opium cultivation belt in western districts of Madhya Pradesh and Rajasthan, the syndicate has repurposed it for manufacturing MDMA. Recent busts in these areas have revealed significant drug production activities linked to Dawood.
Law enforcement agencies recently uncovered a drug manufacturing unit in Village Thavalay, Mhow Tehsil, Indore district, seizing a substantial amount of Methamphetamine or MDMA along with chemicals and equipment. Investigations revealed the sophisticated nature of the lab capable of producing high-grade meth for both domestic consumption and international trafficking. There is a notable trend towards producing drugs within India for smuggling through southern and northeastern borders.
The Dawood Syndicate’s strategy involves smuggling drugs out of India rather than bringing them in, given the heightened border security. Investments in establishing advanced labs for meth production indicate a focus on the international market. The syndicate’s operations are overseen by Salim Dola, who coordinates activities in India from Turkey, channeling funds for lab setups in Pakistan and Dubai.
